See more : Totetsu Kogyo Co., Ltd. (1835.T) Income Statement Analysis – Financial Results
Complete financial analysis of Meso Numismatics, Inc. (MSSV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Meso Numismatics, Inc., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Public Joint-Stock Company Investment Company IC Russ-Invest (RUSI.ME) Income Statement Analysis – Financial Results
- WWPKG Holdings Company Limited (8069.HK) Income Statement Analysis – Financial Results
- Spirent Communications plc (SPMYY) Income Statement Analysis – Financial Results
- FenixOro Gold Corp. (FDVXF) Income Statement Analysis – Financial Results
- Celebrus Technologies plc (DFORF) Income Statement Analysis – Financial Results
Meso Numismatics, Inc. (MSSV)
About Meso Numismatics, Inc.
Meso Numismatics, Inc. engages in the numismatic business in the United States and internationally. The company sells coins, paper currency, bullion, and medals through live auctions. It also offers banknote scanner, an application to identify key characteristics of a banknote; and sells its products through an online store, mesocoins.com. In addition, the company provides CELLGENIC FLOW EXOSOMES; CELLGENIC MSC, which excretes growth factors, cytokines, and proteins for regeneration of tissue; CELLGENIC LUMA that is derived from human umbilical cord mesenchymal stem cells, including potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins, and UV radiation reducing agents for skin revitalization; VITANOVAS that offers in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases; GCELL RESTORE, a closed-system medical device to harness the natural and restorative capabilities of adipose tissue; CELLGENIC SVF, an isolation kit system that has the ingredients and consumables for the extraction of adipose-derived stem cells from fat; CELLGENIC BONE MARROW; and CELLGENIC Platelet Rich Plasma for healing and reducing inflammation. Further, it offers training services to doctors. The company was formerly known as Pure Hospitality Solutions, Inc. and changed its name to Meso Numismatics, Inc. in September 2018. Meso Numismatics, Inc. was founded in 1999 and is based in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.41M | 1.53M | 475.26K | 55.08K | 30.10K | 50.12K | 29.24K | 0.00 | 5.41K | 0.00 |
| Cost of Revenue | 1.13M | 653.26K | 330.01K | 43.95K | 55.52K | 15.04K | 4.81K | 0.00 | 3.00K | 0.00 |
| Gross Profit | 1.28M | 876.97K | 145.25K | 11.13K | -25.42K | 35.08K | 24.43K | 0.00 | 2.41K | 0.00 |
| Gross Profit Ratio | 52.93% | 57.31% | 30.56% | 20.20% | -84.45% | 70.00% | 83.55% | 0.00% | 44.51% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.59M | 1.59M | 9.90M | 458.50K | 1.51M | 284.55K | 522.35K | 424.19K | 459.95K | 517.30K |
| Selling & Marketing | 476.99K | 317.80K | 134.14K | 247.00 | 55.16K | 5.73K | 2.72K | 14.86K | 145.02K | 5.06K |
| SG&A | 1.99M | 1.91M | 10.04M | 458.75K | 1.56M | 290.27K | 525.07K | 451.05K | 604.97K | 623.36K |
| Other Expenses | 2.46K | 152.74K | 40.86K | 800.00 | 800.00 | 46.45K | 2.23K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.99M | 2.06M | 10.08M | 459.55K | 1.57M | 290.27K | 525.07K | 847.15K | 458.94K | 1.99M |
| Cost & Expenses | 3.13M | 2.72M | 10.41M | 503.50K | 1.62M | 305.31K | 529.88K | 847.15K | 461.94K | 1.99M |
| Interest Income | 0.00 | 4.40M | 2.72M | 4.20M | 570.99K | 0.00 | 0.00 | 3.36M | 1.47M | 1.85M |
| Interest Expense | 6.49M | 4.40M | 2.72M | 4.20M | 570.99K | 528.40K | 383.66K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 310.10K | 152.74K | 40.86K | 800.00 | 800.00 | 200.00 | 211.14K | 451.05K | 610.02K | 636.89K |
| EBITDA | -3.01M | -1.02M | -10.11M | -1.69M | -1.94M | -1.53M | 6.65K | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | -16.81% | -67.45% | -2,081.36% | -812.64% | -5,282.89% | -508.81% | -1,704.51% | 0.00% | -24,325.54% | 0.00% |
| Operating Income | -715.23K | -1.18M | -9.93M | -448.42K | -1.59M | -255.19K | -500.64K | -451.05K | -610.02K | -636.89K |
| Operating Income Ratio | -29.68% | -77.43% | -2,089.96% | -814.10% | -5,285.55% | -509.20% | -1,712.12% | 0.00% | -11,271.62% | 0.00% |
| Total Other Income/Expenses | -9.42M | -4.73M | -3.27M | -5.45M | -918.04K | -1.80M | 123.64K | -3.76M | -1.32M | -3.22M |
| Income Before Tax | -9.81M | -5.58M | -12.88M | -5.90M | -2.51M | -2.06M | -377.01K | -4.21M | -1.93M | -3.84M |
| Income Before Tax Ratio | -407.21% | -364.33% | -2,711.03% | -10,703.47% | -8,335.20% | -4,105.61% | -1,289.31% | 0.00% | -35,597.15% | 0.00% |
| Income Tax Expense | -2.00 | -81.81K | 2.72M | 4.20M | 570.99K | -1.27M | 383.66K | -3.76M | -1.32M | -3.21M |
| Net Income | -9.81M | -5.49M | -15.61M | -10.10M | -3.08M | -2.06M | -377.01K | -4.21M | -1.93M | -3.84M |
| Net Income Ratio | -407.21% | -358.99% | -3,284.27% | -18,336.32% | -10,231.98% | -4,105.61% | -1,289.31% | 0.00% | -35,597.15% | 0.00% |
| EPS | -0.79 | -0.45 | -1.36 | -1.08 | -0.58 | -0.50 | -0.11 | -2.34 | -7.82 | -15.60 |
| EPS Diluted | -0.79 | -0.45 | -1.36 | -1.08 | -0.58 | -0.50 | -0.11 | -2.34 | -7.82 | -15.60 |
| Weighted Avg Shares Out | 12.45M | 12.22M | 11.48M | 9.34M | 5.31M | 4.09M | 3.47M | 1.80M | 246.32K | 246.32K |
| Weighted Avg Shares Out (Dil) | 12.45M | 12.22M | 11.48M | 9.34M | 5.31M | 4.09M | 3.47M | 1.80M | 246.32K | 246.32K |
Meso Numismatics Changes Name to Regenerative Medical Technology Group and Ticker Symbol to RMTG
Meso Numismatics Announces Cellgenic's Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September
Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSCG) Launch of Revolutionary New Line of Peptides
Meso Numismatics Announces Intention to Undergo Name Change and Authorized Shares Change
Meso Numismatics Increases 2023 Sales By 50% Year Over Year and Announces 2024 Forecast and Outlook
Meso Numismatics Closes Global Stem Cell Group Acquisition
Meso Numismatics and Global Stem Cell Group Enter Final Definitive Agreement
Meso Numismatics Announces Final Post Closing Agreement
Meso Numismatics Shareholder Update
Meso Numismatics Eliminates All Convertible Debt In Renegotiation Deal and Files 10K
Source: https://incomestatements.info
Category: Stock Reports